"One of the most widely used applications of A. hippocastanum is in the treatment of poor
circulation, and its associated conditions. Whilst many of these studies rely on oral
delivery of the extracts to improve circulation, conditions such as varicose veins, phlebitis
and post-thrombotic syndrome have all been treated using gels containing escin [5, and
refs. therein], suggesting that the topical administration of extracts, as would be the case
in the application of cosmetics, is potentially an equally valid delivery system.
The positive effects of A. hippocastanum extracts on circulation are due to a range of
complex interactions with veins, the lymphatic system, capillaries and connective tissue.
Extracts of A. hippocastanum have been demonstrated to possess venotonic effects in vitro
and in vivo, in both animal and human systems [5, and refs. therein]. For example, A.
hippocastanum extract led to an increase in pressure of flow through both normal and
constricted isolated veins, and an increased effect of noradrenaline on increasing the blood
pressure (and consequently flow) through such vessels [18]. Similarly, capillaries have
been shown to be strengthened by administration of A. hippocastanum extract.
In addition to the direct effects of A. hippocastanum extract on blood vessels, benefit
may also be gained from the protective effects of the extract on connective tissues which
surround the capillary vessels. In chronic venous insufficiency, the capillaries become
highly permeable, resulting in water and proteins leaving the vascular system, which in
turn cause swelling; this may be as a result of the degradation of the extracellular matrix
surrounding the microvasculature (Figure 5). The main component of this extracellular
matrix is hyaluronic acid, a simple glucosaminoglycan consisting of up to several thousand
sugar residues; levels of this compound are usually regulated by the enzyme hyaluronidase,
which promotes the degradation of hyaluronic acid. Recently, escin and its aglycone,
escinol, have been demonstrated to possess non-competitive antihyaluronidase activity
(Table IV), even at concentrations well below that expected as a result of topical
application of these compounds [11].
This inhibition of hyaluronidase should lead to the recovery of the integrity of
hyaluronic acid, and consequently the extracellular matrix surrounding the micro-
vasculature, and may therefore be responsible for some of the beneficial effects of A.
hippocastanum extracts." (wilkinson1999)
"One of the conditions associated with venous insufficiency is the development of
oedematous panniculopathies (inflammation of the sub-cutaneous layer of fat, leading to
tender nodules, typically on the thighs and breasts), and this condition has recently been
treated with phytochemicals from horse chestnut. Application of an emulsion containing
escin and biological carriers, such as β-sitosterol and phosphatidylcholine, over a 30 day
treatment period, led to significant improvements to both thigh and breast pauniculopathies
in human volunteers. These improvements were ascribed to improvements in micro-
circulation, as recorded by Laser Doppler Flowmetry, resulting in reduced swelling and
normalisation of skin temperature...." (wilkinson1999)
"In addition to the existing uses of extracts of horse chestnut as treatments for venous
insufficiency, preparations containing phytochemicals from horse chestnut have consider-
able potential for inclusion in a range of cosmetic formulations. Inclusion of horse chestnut
extracts (especially those from the seeds of the plant, rather than the more poorly-
characterised extracts from leaf and bark tissue) could result in a number of beneficial
actions on the skin after topical administration. Such effects would include potent anti-
oxidative activity, which could help decrease the visible signs of skin ageing, anti-bacterial
and anti-viral properties (largely due to flavonoids), reduction in skin reddening and
cutaneous swelling as a result of effects on capillary vessels and their surrounding con-
nective tissues (due to saponins and the epicatechin dimer proanthocyanidin A2) and also
the potential synergistic enhancement of the efficacy (SPF) of sun screens." (wilkinson1999)
"In 1980, the applications of horse chestnut and escin to cosmetic products were described
for treating the following areas: scalp, oral cavity, face, body, hands, legs and feet, body
hygiene, foot hygiene, intimate hygiene and prevention of haemorrhoids [14]. Recently, it
has been reported that extracts of horse chestnut [or escin at 0.25–0.5% (w/v)] have been
included in a range of commercial products which apply to these areas, including
shampoos, shower foams, foam baths, creams, lotions and toothpastes [15]. Horse chestnut
seeds are on the Medicines Control Agency’s General Sales List in the UK [2] for external
use only. In Germany, they are the subject of a positive therapeutic monograph, indicated
for venous insufficiency, although in the United States, they are of undetermined
regulatory status [15]." (wilkinson1999)
"Horse chestnut is an astringent, anti-inflammatory herb that helps to tone the vein walls which, when slack or distended, may become varicose, haemorrhoidal or otherwise problematic[254]. The plant also reduces fluid retention by increasing the permeability of the capillaries and allowing the re-absorption of excess fluid back into the circulatory system[254]." [PFAF]
"The extracts of horse chestnut show beneficial effects on
venous insufficiency and have many positive pharmacological
effects on the skin 5. The aescin is a potent anti-inflammatory
principle, which also reduces capillary fragility and prevents
leakage of fluids into surrounding tissues. These saponins have
also been used in shampoos, shower foams, creams, lotions,
and toothpastes." (kapusta2007)
"Some different specialties, containing bioactive principles from horse-chestnut (tree bark, bud, flowers and other
parts, may be safely used for specific targets) are now commercially available in the world (Deli, Matus, and Toth,
2000). So, among others, we appraise that some saponin
constituents, also named escins, extracted from Aesculus
hippocastanum L. seeds, have shown satisfactory evidence
for a significant clinical activity in some specific therapies.
The same is valid for oil extracted from the seeds, that gives
some other benefits on therapeutic treatments. Furthermore, it has been proven by many clinical trials that these
natural extracts are effective adjuvants in compression therapy as an alternative medical treatment (Sirtori, 2001), in
addition to an ethanol absorption-inhibitory effect and
hypoglycemic activity (Yoshikawa et al., 1996). Moreover,
it has been described in the literature by Konoshima and
Lee (1986) the cytotoxic and antitumoral activity of some
sapogenols extracted from Aesculus hippocastanum L., in
particular hippocaesculin and barringtogenol-C." (baraldi2007)
"Triterpene and steroid saponins and sapogenins of medicinal plants
(Aesculus hippocastanum L., Hedera helix L., Ruscus aculeatus
L.) are claimed to be effective for the treatmen/prevention of
venous insufficiency." (facino1995)
"Constituents from Aesculus hippocastanurn L. show inhibitory effects only on
hyaluronidase, and this activity is mainly linked to the saponin escin (IC50
= 149.9 μg), less to its genin escinol (IC50 = 1.65 mM)." (facino1995)
"Their active constituents are saponins and sapogenins with
different chemical structures: triterpene (escin and escinol
from Aesculus hippocastanum L. seeds, ...." (facino1995)
"Both the saponins Hederacoside C and a-hederin had no
anti-hyaluronidase activity. By contrast, of the active principles of Aesculus hippocastanurn L., Escin had the highest
activity (IC50= 149.9 μg), inhibiting hyaluronidase from
50 μg (4.2 +/- 0.6 % inhibition); at higher concentrations 100,
150, 200, and 300 μg,
the enzyme activity was inhibited by
27.4 +/- 2.2 %, 52.0 +/- 2.4 %, 79.2 +/- 4.2 % and 93.6 +/- 3.4 %
respectively (Fig. 4). The aglycon escinol was much less
active (IC50 = 1.65 mM), and the ruscogenins were totally
ineffective." (facino1995)
"Escin and escinol have no anti-elastase activity: they inhibit
only lysosomal hyaluronidase, probably through a cooperative mechanism (aglycone plus glycoside).
The weak inhibition by escin observed in vitro compared with the remarkable
venotonic, vasculotropic and anti-exudative activity found in
vivo in animal models 21, indicates that this saponin can
affect other enzymes of the extravascular matrix (collagenase, P-glucuronidase) and/or acts
through other mechanisms (such as those involving inhibition of prostaglandin and
leukotriene synthetases)." (facino1995)
"Although other constituents may have some bioactivity,
the polyhydroxylated triterpenoid glycosides (saponins) in
Aesculus extract are considered to be the major active principles. To date, the saponins from the seeds of six species including A. hippocastanum (AH), A. chinensis var. chinensis
(ACC), A. chinensis var. wilsonii (ACW), A. turbinata (AT),
A. assamica (AA), and A. pavia (AP) have been well documented. Very interestingly, the saponins from four Eurasian
species (AH, ACC, ACW, and AT) have very similar structures but are different from the novel cytotoxic saponins
from an eastern North American species A. pavia. This
chemical difference suggests a chemotaxonomic significance
between the two groups 13, 61." (Shiyou Li et al.,2010)
"As found in different animal tests and preclincal investigations, the principal ingredient of Horse Chestnut seed extract,
triterpene glycoside mixture (aescin), has an anti-exudative,
vascular tightening effect, and reduction of vascular permeability which result in an antiedemic effect. The vein-toning
properties of the Horse Chestnut extract also demonstrated
improvement of venous return flow. A significant reduction
of transcapillary filtration was seen in a placebo-controlled
human pharmacological trial (Bisler, 1986). Significant
improvement in the symptoms of chronic venous insufficiency was demonstrated in diverse, randomized, double-blind
and cross-over studies (Calabrese, 1993; Steiner, 1990).
There are indications that Horse Chestnut seed extract
reduces the activity of lysosomal enzymes, which increases
in chronic pathological conditions of the veins. The enzymes
will break down glycoacalyx (mucopolysaccharides) in the
region of the capillary walls, allowing proteins to leak into
the interstitium. The activity of the enzymes is reduced by
the aescin and so the breakdown of glycoacalyx is also
inhibited. The transcapillary filtration of low-molecular
proteins, electrolytes and water into the interstitium is
inhibited through a reduction of vascular permeability by the
aescin." [PDR]
"The horse chestnut extracts have been demonstrated to be
a potent scavenger of active oxygen. This showed the highest
activity of 65 plant extracts tested, was more powerful than
vitamin E, and exhibited a potent cell-protective effect linked
to antiaging properties of antioxidants 6. The major
principles of these activities are flavonoids present in the
extracts. This group of secondary metabolites shows radical
scavenging, antibacterial, and antiviral activities, and they
are used in varicosis and capillary fragility. Recent work on
flavonoids from the seeds of Aesculus chinensis demonstrated
their activity against parainfluenza virus type 3 and influenza
virus type A 6. Regarding the flavonoids from Aesculus
hippocastanum, literature provides inconsistent data. The
detailed work on structural characterization of flavonoids was
performed by Hübner and co-workers and showed that they
were glycosides of quercetin and kaempferol and some of
them occurred as acylated forms 8. In the conclusion of
this work, however, the authors pointed out that the concentration of these compounds in horse chestnut seeds is low
(0.3%, calculated as rutin equivalent) and their contribution
to the therapeutic efficacy of crude drug is unlikely. This
statement remains inconsistent with the literature data cited
above indicating the main role of horse chestnut flavonoids
in radical scavenging activity of the extracts." (kapusta2007)
"Aesculin extracted from the Horse Chestnut (Aesculus hippocastanum) goes into the phytotherapeutic
preparations for the treatment of capillary fragility." (gurib-fakim2006)
"The anti-inflammatory activities are
often attributed to the presence of saponins while the antioxidant activity attributed
to the presence of flavonoids and other molecules having antioxidant activities.
Among the plants that have contributed shown prominence are: Horse chestnut
(Aesculus castanea) and Gingko (Gingko biloba)." (gurib-fakim2006)
"Traditionally, the dried ripe seeds have been
used in the treatment or coronary heart disease. The main constituents are the triter-
pene saponins (up to 10%) and are collectively known as Aescin (a-aescin, b-aescin
and cryptoaescin) and they are considered to be the major therapeutic principles of
the seeds. b-Aescin is a mixture of more than 30 different glycosides derived from the
triterpene aglycones protoaescigenin (also known as protoescigenin) and barrintogenol C. Other
constituents present include the flavonoids (e.g. quercetin, kaemferol
and their glycosyl derivatives)." (gurib-fakim2006)
"Hydroalcoholic extracts of the seeds have been tested in canine saphenous veins
in vitro, and an intravenous bolus (25–30 mg) increased venous pressure in perfused
canine saphenous veins, in vivo. Placebo-controlled clinical trials have been carried
out to assess the efficacy of oral administration of standardized extracts (250–
600 mg) equivalent to 100–150 mg aescin daily, in the treatment of Chronic Venous
Insufficiency (CVI). Clinical studies have shown symptomatic improvement in skin
colour, venous prominence, oedemas etc in treated patients. Pregnancy-related varicose veins
in women, swollen legs during long (15 h) flights also responded positively
to treatment. Double-blind placebo-controlled in healthy volunteers also showed
improvement in capillary- resistance (WHO, 2002)." (gurib-fakim2006)
"We investigated the anti-inflammatory activities of the pure escins in acute inflammatory models. Escins
dose-dependently exhibited inhibitory effects on the increase of vascular permeability by acetic acid in mice,
and on the earlier phase of swelling by carrageenin in rats. Escins also inhibited histamine- or serotonin-
induced increase of vascular permeability, excepting escin Ia on serotonin-inducedone. Escin Ib (2) showed
significant inhibition on the second phase of swelling by carrageenin, and escins IIa (3) and IIb (4) also
showed tendency to inhibit it. These results indicate that escins, given orally, effect on the early exudative
stage of inflammation and itch owing to these chemical mediators and suggest that these inhibitory effects are
mainly depend on their anti-histaminic and anti-serotonic activities, though the effects of escins against kinin
formation and arachidonic acid cascade are not clarified." (matsuda1997)
"In this study, it has become apparent that escins have antiinflammatory activities in the acute stage, but
there are differences among the activities of escins, especially anti-serotonic activity. Furthermore the
differences of chemical structure in acyl groups and in oligosaccharide moiety are apparently be important to
exhibit the antiinflammatory activity." (matsuda1997)
"The therapeutic benefits of HCSE and aescin for the
treatment of chronic venous insufficiency, hemorrhoids, and
postoperative edema are due to their significant antiinflammatory properties, which were demonstrated in animal
models 5, 50, 84, 85]. The anti-inflammatory activities of
HCSE or aescin are related to the molecular mechanism of
the agents, which include the improved entry of ions into
channels 86 thus raising venous tension 87, the release of
prostaglandin-F2a from veins 88, the release of inflammatory mediators by decreasing leukocyte activation and adhesiveness 84, 89, the antagonism to the pro-inflammatory 5-
HT receptors and histamine 90, and the decrease in the
activity of tissue hyaluronidase 91." (Shiyou Li et al.,2010)
"... pharmacopeiae report only few information about the grade quality of horse-chestnut seeds, which
is the most widely used starting material required for manufacturing the above specified native dry extracts. These
pharmacopeiae establish that the dry extracts, from the
dried seeds of Aesculus hippocastanum L., must contain
not less than 3.0% of triterpene glycosides, calculated as
anhydrous escin, with reference to the dried drug." (baraldi2007)
"The typical drug-to-extract ratio for this native dry extract,
will fall within the range of 5.0–8.0:1 (w/w), depending on
the chemical composition of the starting material and the
subsequent yield of soluble extractive." (baraldi2007)
"Isoescins Ia (43) and Ib (44) and escins Ia (21), Ib (22),
IVc (28), IVd (29), IVe (30), and IVf (31) isolated from the
seeds of A. chinensis var. chinensis showed activity against
HIV-1 protease. Escins Ia (21) and Ib (22) inhibited the enzyme’s activity by 86.1 ± 0.2% at 100 µM with IC50 values
of 35 and 50 µM, respectively, while saponins 28-31, 43, and
44 showed weaker antiviral activity 47.
Three flavonol glycosides of aescuflavoside (103), aescuflavoside A (105), and leucoside (120) from A. chinensis var.
chinensis showed significant antiviral activities against respiratory syncytial virus with IC50 values of 4.5, 6.7, and 4.1
µg/mL, and selective index values of 15.8, 32, and 63.8, respectively. Astragalin (122) demonstrated significant antiviral activity against influenza virus type A with an IC50 of
24.5 µg/mL and a selective index of 16.0 66.
Pavietin (161), a new prenylated coumarin, isolated from
the leaves of a genotype of A. pavia, showed antifungal activity. In a preliminary antifungal screening by filter disk
method, pavietin (15 mg/dish) possessed significant activity
against an Aesculus-specific fungal parasite, Guignardia
aesculi, and weaker activity against the generalist polyphagous Pythium ultimum and the Aesculus nonpathogenic
Fusarium basilici. More detailed antifungal screening by
adding pavietin to mycelial growth medium of different fungal pathogens showed that pavietin exhibits appreciable antimicrobial properties against several pathogens including
Alternaria alternata, A. dianthi, Aspergillus niger, Botrytis
cinerea, Cladosporium fulvum, Fusarium oxysporum dianthi,
Guignardia aesculi, Penicillium expansum, Polyporus marginatus, Rhizopus stolonifer, and Trichoderma viride 67." (Shiyou Li et al.,2010)
"Slimy bacteria Sporocytophaga species was reported to be inhibited by the leaf extracts of Aesculus
hippocastanum and Acer platanoides, which
contain considerable amounts of polyphenols, tannic acids, coumarin,
and flavonoglucids.219 Field and Lathinga220 reported
that the growth of methanogenic bacteria
was affected by tannins." (chung1998)
"...we mention that Fant,
Vranken, and Borremans (1999) report that antimicrobial
protein 1 (Ah-AMP1), isolated from horse-chestnuts and
whose structure has been resolved via 1H NMR techniques,
is a very effective plant defence in that it inhibits growth of
a broad range of fungine species." (baraldi2007)
"Many reports suggest a link between skin ageing and active oxygen species, especially
when combined with ultra-violet radiation. Recently, an extract of A. hippocastanum has
been shown to be highly effective in reducing the production and damaging effects of
active oxygen species in vitro, using both biochemical and biological assays 16." (wilkinson1999)
"The main active principles of the anti-exudative effect and
improvement of venous tone are hydroxycoumarins (aesculin
and fraxin), triterpene saponins in the petioles and leaf veins,
flavonoids and a rich supply of tannins. Although the drug is
said to have an anti-exudative effect and improve venous
tone, there is a lack of clinical data to support the efficacy."[PDR]
Can Aesculus treat cancer?
Research indicates that β-escin and specific acyl-saponins possess significant antitumor
properties. While much research is in vitro (petri dish), animal studies have shown promising results. For example,
Aescin from A. chinensis var. wilsonii demonstrated a 43.5% inhibition rate on H22 tumor
growth in mice at doses of 2.8 mg/kg. However, because effective cytotoxic doses in humans are estimated to be high,
these compounds are currently viewed as potential inhibitors of cancer progression rather than standalone cures.
G1-S Cell Cycle Arrest
Target: Colon Cancer (HT-29), Leukemia
β-escin acts like a brake pedal at the G1-S Phase checkpoint. It prevents the
cell from moving from "Growth" to "DNA Replication" by:
- Boosting p21 (WAF1/CIP1): A protein that halts division (the "Red Light").
- Reducing Cyclins A & E: Removing the proteins that drive the cell forward (the "Gas Pedal").
- Reducing Rb Phosphorylation: Keeping the "Rb" protein in a locked state.
Source: A. hippocastanum, A. chinensis
Apoptosis & Alternative Death
Target: Leukemia (HL-60, K562), Liver (HepG2)
Compounds force cancer cells to die via controlled pathways:
- Classic Apoptosis: Marked by DNA fragmentation and Annexin V+ markers (Leukemia).
- Caspase-Independent Death: A unique "backdoor" cell death pathway observed in liver cancer cells (HepG2), bypassing the usual enzymes.
Source: A. chinensis
Topoisomerase I Inhibition
Target: Lung, CNS, Ovarian, Breast
Specific saponins (Aesculiosides) interfere with the TOP1 Enzyme, which manages DNA tension.
- The Blockade: Saponins bind directly to the free enzyme, preventing it from binding to DNA.
- The Result: If DNA cannot unwind, the cell cannot replicate and eventually dies.
Source: A. pavia
⚗️ Structure-Activity Relationship (SAR): Why Shape Matters
Not all horse chestnut compounds are equal. Research on A. pavia saponins revealed that the
chemical shape determines potency. Specifically, the number of Acyl Groups (chemical attachments at C-21 and C-22) acts like teeth on a key.
Two Acyl Groups
🔑🔑
High Potency
(GI50 0.175–8.71 µM)
Examples: Saponins 94, 96, 98
Active against 59 cell lines.
One Acyl Group
🔑
Reduced Activity
Examples: Aesculiosides IIc, IId
Significantly less effective at inhibiting growth.
No Acyl Groups
🚫
Inactive
Examples: Aesculiosides Ia-e
Without these "teeth," the molecule has almost no effect.
🧪 The Prosapogenin Mystery:
Interestingly, when researchers stripped sugars from these saponins to create prosapogenins, the resulting compounds became stronger cell killers but stopped inhibiting TOP1. This implies that while Saponins attack DNA enzymes, their derivatives likely use a completely different, unknown mechanism to kill cancer cells.
| Term |
Simplified Definition |
Context in Aesculus Research |
| In vivo / In vitro |
In vivo = "In a living body" (e.g., mice). In vitro = "In glass" (e.g., petri dish). |
A. chinensis worked in mice (in vivo); A. pavia was tested in cell cultures (in vitro). |
| Cytotoxicity |
The quality of being toxic to cells (cell-killing power). |
β-escin exhibited cytotoxicity (killed cells) at concentrations of 30 µmol/L. |
| GI50 / ED50 |
The dose required to inhibit cell growth by 50%. Lower numbers mean the drug is stronger. |
Prosapogenins had an ED50 of ~3.0 µg/mL, meaning only a small amount was effective. |
| Caspase-independent |
A cell death pathway that skips the usual "executioner" enzymes (caspases). |
A. chinensis var. wilsonii kills liver cancer cells via this alternative route. |
Research Note: The data above is derived from specific studies on isolated chemical constituents. Whole plant preparations may not carry these concentrations. Always consult an oncologist before considering herbal adjuncts for cancer therapy. This was an Google Gemini AI summary of the data from (Shiyou Li et al.,2010)
Click to view cancer research excerpts and notes
"Recent studies in vivo and in vitro indicate that aescin (β-escin) has significant antitumor activities.
β-escin from A. hippocastanum inhibited chemically induced colon carcino-
genesis in rats, and in vitro exhibited cytotoxicity at 30
µmol/L or above concentrations in colon cancer cell lines. β-Escin at 5 µmol/L also inhibited HT-29 colon cancer cell
proliferation. β-escin induced cell cycle arrest at G1-S phase
in part mediated by induction of p21WAF1/CIP1 and/or associated with reduced levels of Cdk2 and cyclins A and E
complex; additionally, there was a lower phosphorylation of
Rb [93]." (Shiyou Li et al.,2010)
"β-escin isolated from the seeds of A. chinensis var.
chinensis induced apoptosis and caused a significant inhibition of HL-60 human acute myeloid leukemia cell and K562-
huamn chronic myeloid leukemia cell proliferation in dose- and time-dependent fasion. Morphological evidence of apoptosis, a significant increase of annexin V+ and PI- cells
(early apoptotic) and apoptotic DNA fragmentation, were
observed in K562 cells treated with β-escin. Flow cytometry
analysis indicated that β-escin induced G1-S arrest and led to
a significant accumulation of the sub-G1 population in HL-
60 and K562 cells 94, 95." (Shiyou Li et al.,2010)
"Aescin isolated from the seeds of A. chinensis var. wilsonii at a dose of 2.8 mg/kg had a rather high inhibition ratio
(43.5 %) on mice H22 tumor growth in vivo. Aescin could
induce significant concentration- and time-dependent inhibition of HepG (2) cell viability and
induce cell cycle checkpoint arrest and caspase-independent cell death in HepG (2)
cells 96." (Shiyou Li et al.,2010)
"An early investigation showed that two prosapogenins of
21-O-tigloyl-22-O-angeloyl-R1-barrigenol (10) and 21-O-
angeloylbarringtogenol-C (18) from the acid hydrolysates of
the HCSE of A. hippocastanum exhibited significant in vitro
cytotoxicity with ED50 of 3.6 µg/mL and 3.0 µg/mL, respectively, in the human nasopharyngeal carcinoma 9-KB cell
culture assay 27." (Shiyou Li et al.,2010)
"More recently, 28 individual saponins (72-99) from the
fruits of A. pavia and six prosapogenins produced from these
saponins were assayed in vitro for their cytotoxicity and inhibition of DNA topoisomerase I (TOP1) 61, 97
Saponins
94, 96 and 98 with two acyl groups at C-21 and C-22
showed activity with GI50 of 0.175–8.71 µM against most of
59 cell lines tested, which were from nine different human
cancers including leukemia, non-small cell lung, colon, central nervous system (CNS), melanoma, ovarian, renal, prostate, and breast tumor cell lines.
Aesculiosides IIc (79) and
IId (80) with only one acyl group at C-21 showed less activity while aesculiosides Ia-e (72-76) without acyl group
showed no or weak activity 61.
Aesculiosides IIa-k (77-
87), IIIa-f (88-93), IVa (95), IVb (97), IVc (99), saponins 94,
96, 98 and six prosapogenins were also tested for their inhibition of DNA topoisomerase I (TOP1) and their activities
against A549, PC-3, HL-60, PANC-1, and MRC cell lines.
Most of the tested saponins and prosapogenins with acyl
groups showed cytotoxic activity with different GI50 value.
Sixteen cytotoxic aesculiosides 77-80 and 88-99 inhibited
TOP1 catalytic activity by interacting directly with the free
enzyme and preventing the formation of the DNA-TOP1
complex. Interestingly, six prosapogenins, including 21-O-
angeloylproaescigin (13), 21,22-O-diangeloylprotoaescigenin
(16), 21,22-O-diangeloylbarringtogenol-C (20), 21-O-angelyol-22-O-2-methylbutanoyl-R1-barrigenol, 21-O-angelyol-
22-O-2-methylbutanoylprotoaescigenin, and 21-O-angelyol-22-O-2-methylbutanoylbarringtogenol-C prepared from the
acid hydrolysates of saponins 78, 96, 98, 95, 97, and 99,
respectively, showed no TOP1 inhibitory activity, but had
stronger cytotoxicity when compared to the related saponins
97." (Shiyou Li et al.,2010)
"As far as cytotoxicity data are concerned the
following observations can be made. Most studies
were performed on a relatively narrow range of cell
lines, usually from one to five, sometimes up to ten.
The most notable exceptions in this respect are the
reports, in which isolated compounds were assayed by
National Cancer Institute (NCI) in anticancer drug
discovery screen. For example, Zhang (Zhang and Li
2007) tested triterpenoid saponins isolated from
Aesculus pavia against a panel of 59 cell lines from
nine different human cancers such as leukemia, non-
small cell lung, colon, CNS, melanoma, ovarian, renal,
prostate and breast." (Podolak et al,2010)
"Zhang and Li screened five pre-selected saponins
isolated from Aesculus pavia against a panel of 59
cell lines from nine human cancers: leukemia, non-
small cell lung, colon, CNS, melanoma, ovarian,
renal, prostate and breast. These saponins were
polyhydroxyoleanenes with or without acyl groups
at C-21 and/or C-22 and a sugar moiety composed of
a-L-Araf, b-D-GlcAp, b-D-Galp. From the results
obtained with a large array of cancer cell lines it seems that the presence of two acyl groups is
important for cytotoxicity as non-acylated saponins
showed no or only weak activity (Zhang and Li
2007)." (Podolak et al,2010)
"The fruit of Aesculus hippocastanurn L. (horse chestnuts, Hippocastanaceae) has been
used as an herbal remedy for the treatment of mammary indurations and cancer (1).
Prior phytochemical studies (2-5) on this plant have yielded a saponin, aescin, which is
a mixture of the acylated glycosides of protoaesigenin and barringtogenol-C, with
angelic, tiglic, and acetic acids as the acyl groups. As a result ofour continuing searches
among medicinal plants for novel, naturally occurring, potential antitumor agents, the
acid hydrolyzed product of an n-BuOH extract of the fruits of A. hippocastanurn was
found to show significant in vitro cytotoxicity in the 9-KB (human nasopharyngeal car-
cinoma) cell culture assay (6). Bioassay-directed fractionation of the foregoing active ex-
tract led to the isolation and characterization of two cytotoxic sapogenols, the new hippocaesculin
[1, ED50 (KB)=3.6 pg/ml] and the known barringtogenol-C 2 1-angelate
12, ED,, (KB)=3.0 pg-mll. Compound 2 was previously isolated from the leaves of
Pittosporum tobira (7); however, its cytotoxicity is revealed for the first time." (konoshima1986)
Phytochemicals
| AESCIN | Bark, Seed 130000 [DukePhyto] |
| ESCIN | Bark, Leaf, Seed 22000-125300, Tissue Culture [DukePhyto] |
| ALPHA-AESCIN | Fruit, Seed [DukePhyto] |
| BETA-AESCIN | Seed [DukePhyto] |
| CRYPTOAESCIN | Seed [DukePhyto] |
| CRYPTOAESCIN-A | Seed [DukePhyto] |
| CRYPTOAESCIN-B | Seed [DukePhyto] |
| AESCIGENIN | Seed [DukePhyto] |
| PROTOAESCIGENIN | Seed [DukePhyto] |
| BARRINGTOGENOL-C | Seed [DukePhyto] |
| BARRINGTOGENOL-D | Seed [DukePhyto] |
| BARRINGTOGENOL-C-21-ANGELATE | Fruit 4.7 [DukePhyto] |
| FRIEDELIN | Seed [DukePhyto] |
| TARAXEROL | Seed Oil, Seed [DukePhyto] |
| HIPPOAESCULIN | Seed [DukePhyto] |
| HIPPOCAESCULIN | Fruit 3.1 [DukePhyto] |
| HIPPOCASTANINE | Seed [DukePhyto] |
| SAPONINS | Seed 55000-280000 [DukePhyto] |
| BETA-AMYRIN | Bark, Seed Oil [DukePhyto] |
| BUTYROSPERMOL | Seed, Seed Oil [DukePhyto] |
| PARKEOL | Seed Oil [DukePhyto] |
| QUERCETIN | Bark, Seed [DukePhyto] |
| QUERCETOL | Seed [DukePhyto] |
| QUERCITRIN | Bark, Leaf, Seed [DukePhyto] |
| ISOQUERCITRIN | Flower, Leaf [DukePhyto] |
| KAEMPFEROL | Bud, Seed [DukePhyto] |
| RUTIN | Flower, Plant [DukePhyto] |
| EPICATECHIN | Bark [DukePhyto] |
| (-)-EPICATECHIN | Seed Coat 816.3-4000, Leaf, Fruit Epidermis [DukePhyto] |
| PROCYANIDIN-A-1 | Leaf, Fruit Epidermis [DukePhyto] |
| PROCYANIDIN-A-2 | Fruit Epidermis, Seed Coat 510.2-1733.3, Leaf [DukePhyto] |
| PROCYANIDIN-B-1 | Leaf, Fruit Epidermis, Seed Coat 240 [DukePhyto] |
| PROCYANIDIN-B-2 | Leaf, Seed Coat 612.2-3066.7, Fruit Epidermis [DukePhyto] |
| AESCULITANNIN (A-G) | Seed Coat (Various ppm) [DukePhyto] |
| CINNAMTANNIN-B-1 | Seed Coat 408.2 [DukePhyto] |
| LEUCOCYANIDIN | Bark [DukePhyto] |
| TANNIN | Flower, Wood [DukePhyto] |
| OPCS | Seed [DukePhyto] |
| AESCULETIN | Bark [DukePhyto] |
| ESCULETIN | Bark, Seed [DukePhyto] |
| AESCULETOL | Seed [DukePhyto] |
| AESCULIN | Bark 30000, Stem, Seed, Pericarp [DukePhyto] |
| ESCULIN | Bark 30000, Stem, Seed, Pericarp [DukePhyto] |
| AESCULOSIDE | Seed [DukePhyto] |
| FRAXETIN | Bark [DukePhyto] |
| FRAXIN | Bark, Stem, Seed, Pericarp [DukePhyto] |
| SCOPOLETIN | Bark [DukePhyto] |
| SCOPOLIN | Bark, Pericarp [DukePhyto] |
| HIPPOCASTANOSIDE | Pericarp [DukePhyto] |
| 1,8-CINEOL | Flower Essent. Oil 66000 [DukePhyto] |
| ALPHA-PINENE | Flower Essent. Oil 177000 [DukePhyto] |
| BETA-PINENE | Flower Essent. Oil 122000 [DukePhyto] |
| CAMPHENE | Flower Essent. Oil 83000 [DukePhyto] |
| LIMONENE | Flower Essent. Oil 42000 [DukePhyto] |
| BETA-CARYOPHYLLENE | Flower Essent. Oil 13000 [DukePhyto] |
| BENZALDEHYDE | Flower Essent. Oil 11000 [DukePhyto] |
| GERANIOL | Flower Essent. Oil 4000 [DukePhyto] |
| 3-METHYL-BUTAN-1-AL | Flower Essent. Oil 4000 [DukePhyto] |
| BENZYL-FORMATE | Flower Essent. Oil 22000 [DukePhyto] |
| OLEIC-ACID | Seed 18990 [DukePhyto] |
| LINOLEIC-ACID | Leaf, Seed 620-6415 [DukePhyto] |
| PALMITIC-ACID | Leaf, Seed 1245 [DukePhyto] |
| STEARIC-ACID | Leaf, Seed 1015 [DukePhyto] |
| MYRISTIC-ACID | Leaf [DukePhyto] |
| LAURIC-ACID | Leaf [DukePhyto] |
| CHOLESTEROL | Bark, Seed [DukePhyto] |
| BETA-SITOSTEROL | Bark, Seed, Leaf [DukePhyto] |
| STIGMASTEROL | Bark, Seed, Leaf [DukePhyto] |
| CAMPESTEROL | Bark, Seed, Leaf [DukePhyto] |
| ALPHA-SPINASTEROL | Bark, Seed [DukePhyto] |
| FAT | Seed 30000-50000 [DukePhyto] |
| STARCH | Seed 300000-600000 [DukePhyto] |
| CARBOHYDRATES | Seed 740000 [DukePhyto] |
| SUCROSE | Branches [DukePhyto] |
| GLUCOSE | Seed [DukePhyto] |
| STACHYOSE | Seed [DukePhyto] |
| ALLANTOIN | Bark, Leaf, Branches [DukePhyto] |
| URIC-ACID | Plant, Seed [DukePhyto] |
| ADENINE | Flower, Seed [DukePhyto] |
| ADENOSINE | Flower, Seed [DukePhyto] |
| ASCORBIC-ACID | Leaf 147.2, Seed 24 [DukePhyto] |
| VITAMIN-K-1 | Leaf [DukePhyto] |
Note: Data sourced from Dr. Duke's Phytochemical and Ethnobotanical Databases. Values represent Parts Per Million (PPM) unless otherwise noted.
| CINNAMTANNIN-B-2 | Seed Coat 132.7 [DukePhyto] |
| PROCYANIDIN-A-4 | Seed Coat 204.1 [DukePhyto] |
| PROCYANIDIN-B-3 | Leaf, Fruit Epidermis [DukePhyto] |
| PROCYANIDIN-B-4 | Leaf [DukePhyto] |
| PROCYANIDIN-B-5 | Leaf, Fruit, Seed Coat 40-204.1 [DukePhyto] |
| PROCYANIDIN-C-1 | Leaf, Seed Coat 13.3-204.1, Fruit Ep. [DukePhyto] |
| PROCYANIDIN-D-1 | Leaf, Fruit Epidermis [DukePhyto] |
| PROCYANIDIN-D2 | Leaf, Fruit Epidermis [DukePhyto] |
| PROCYANIDIN-E | Leaf, Fruit Epidermis [DukePhyto] |
| PROCYANIDIN-G | Leaf, Fruit Epidermis [DukePhyto] |
| PROANTHOCYANIDIN-A-4 | Seed [DukePhyto] |
| PROANTHOCYANIDIN-A-6 | Seed Coat 17.9 [DukePhyto] |
| PROANTHOCYANIDIN-A-7 | Seed Coat 12.7 [DukePhyto] |
| PROANTHOCYANIDIN-POLYMER | Fruit [DukePhyto] |
| PROANTHOCYANIN-A-2 | Fruit [DukePhyto] |
| EPI-CATECHIN-(4-BETA-6)-EPI-CATECHIN... | Fruit Epidermis 46.6 [DukePhyto] |
| EPI-CATECHIN-(4-BETA-8)-EPI-CATECHIN... | Fruit Epidermis 22.6 [DukePhyto] |
| EPI-CATECHIN-(4-BETA-8,2-BETA-7)-CATECHIN... | Fruit Epidermis 30.6 [DukePhyto] |
| EPI-CATECHIN-(4-BETA-8,2-BETA-7)-EPI-CATECHIN... | Fruit Epidermis 118.6 [DukePhyto] |
| ASTRAGALIN | Flower [DukePhyto] |
| CYANIDIN | Leaf [DukePhyto] |
| FLAVAZIDE | Leaf [DukePhyto] |
| FLAVONES | Seed [DukePhyto] |
| ISOKAEMPFERIDE | Bud [DukePhyto] |
| ISORHAMNETIN | Bud [DukePhyto] |
| JUGLANIN | Plant [DukePhyto] |
| KAEMPFEROL-3-RHAMNOFURANOSIDE | Leaf, Flower [DukePhyto] |
| KAEMPFEROL-4',7-DIMETHYL-ETHER | Bud [DukePhyto] |
| LEUCOANTHOCYANS | Leaf [DukePhyto] |
| LEUCODELPHINIDIN | Bark [DukePhyto] |
| LUTEOLOL | Seed [DukePhyto] |
| MYRICETIN | Plant [DukePhyto] |
| MYRICETIN-3',4',7-TRIMETHYL-ETHER | Bud, Seed [DukePhyto] |
| QUERCETIN-3',4',7-TRIMETHYL-ETHER | Bud [DukePhyto] |
| QUERCETOSIDE | Seed [DukePhyto] |
| RHAMNAZIN | Bud [DukePhyto] |
| RHAMNETOL | Seed [DukePhyto] |
| RHAMNOCITRIN | Bud, Flower [DukePhyto] |
| RUTOSIDE | Seed [DukePhyto] |
| XANTHORHAMNOSIDE | Seed [DukePhyto] |
| 1-KESTOSE | Seed [DukePhyto] |
| 2-KESTOSE | Seed [DukePhyto] |
| GALACTOSE | Pericarp, Seed [DukePhyto] |
| XYLOSE | Seed [DukePhyto] |
| MYO-INOSITOL | Pericarp [DukePhyto] |
| QUEBRACHITOL | Branches, Leaf [DukePhyto] |
| (-)-QUERBRACHITOL | Pericarp [DukePhyto] |
| 2-CARBOXYARABINITOL | Leaf 11 [DukePhyto] |
| CITRIC-ACID | Bark [DukePhyto] |
| ACETIC-ACID | Seed [DukePhyto] |
| GLUCURONIC-ACID | Seed [DukePhyto] |
| ANGELIC-ACID | Seed [DukePhyto] |
| TIGLIC-ACID | Seed [DukePhyto] |
| PROTEIN | Seed 80000-110000 [DukePhyto] |
| AMINO-ACIDS | Leaf [DukePhyto] |
| HISTIDINE | Leaf [DukePhyto] |
| L-(+)-LYSINE | Seed [DukePhyto] |
| L-(-)-TRYPTOPHAN | Seed [DukePhyto] |
| SERINE | Leaf [DukePhyto] |
| ASH | Seed 14000-30000 [DukePhyto] |
| WATER | Seed 30000-400000 [DukePhyto] |
| 5-HYDROXY-METHYL-FURFURAL | Flower Essent. Oil 4000 [DukePhyto] |
| BUTYL-ACETATE | Flower Essent. Oil 21000 [DukePhyto] |
| GAMMA-BUTYROLACTONE | Flower Essent. Oil [DukePhyto] |
| DECAN-1-OL | Flower Essent. Oil 82000 [DukePhyto] |
| DODEC-2-EN-1-OL | Flower Essent. Oil 14000 [DukePhyto] |
| NONAN-1-AL | Flower Essent. Oil 23000 [DukePhyto] |
| TRIDEC-2-EN-1-OL | Flower Essent. Oil 34000 [DukePhyto] |
| ALPHA-AMURIN | Seed Oil [DukePhyto] |
| ALPHA-CAROTENE | Leaf [DukePhyto] |
| PROVITAMIN-D | Seed 0.9 [DukePhyto] |
| PHYTOSTEROLS | Plant [DukePhyto] |
| SITOSTEROL | Leaf [DukePhyto] |
| SPINASTEROL | Seed [DukePhyto] |
| CAMPEST-7-EN-3-BETA-OL | Seed [DukePhyto] |
| PLASTOQUINONE-8 | Seed [DukePhyto] |
| QUINONES | Seed [DukePhyto] |
| POLYPRENOLS | Leaf [DukePhyto] |
| TRIACONTANE | Seed [DukePhyto] |
| PALMITOLEIC-ACID | Leaf [DukePhyto] |
| ALPHA-METHYL-BETA-HYDROXYBUTYRIC-ACID | Seed [DukePhyto] |
| ELEUTHEROSIDE-B-1 | Stem [DukePhyto] |
| CHOLINE | Flower [DukePhyto] |
| GUANINE | Flower, Seed [DukePhyto] |
| UREA | Leaf [DukePhyto] |
| ALLANTOIC-ACID | Leaf [DukePhyto] |
| APS-SULFOTRANSFERASE | Leaf [DukePhyto] |
| (-)-QUINIC-ACID | Pericarp [DukePhyto] |
| Aglycone / Derivative |
Primary Source |
| R1-Barrigenol | A. glabra, A. pavia (Shiyou Li et al.,2010) |
| 24-Hydroxy-R1-barrigenol | A. pavia, A. californica (Shiyou Li et al.,2010) |
| 21-O-angeloyl-R1-barrigenol | A. glabra (Shiyou Li et al.,2010) |
| 22-O-angeloyl-R1-barrigenol | A. glabra (Shiyou Li et al.,2010) |
| 21,22-O-diangeloyl-R1-barrigenol | A. glabra (Shiyou Li et al.,2010) |
| Aglycone / Derivative |
Primary Source |
| Protoaescigenin | A. hippocastanum, A. indica (Shiyou Li et al.,2010) |
| Barringtogenol-C | A. hippocastanum, A. assamica (Shiyou Li et al.,2010) |
| Aescigenin | A. hippocastanum, A. chinensis (Shiyou Li et al.,2010) |
| Barringtogenol-D | A. hippocastanum (Shiyou Li et al.,2010) |
| 16-O-acetylprotoaescigenin | A. hippocastanum (Shiyou Li et al.,2010) |
| Compound |
Source Species |
| Escin Ia, Ib, IIa, IIb | A. hippocastanum, A. turbinata, A. chinensis (Shiyou Li et al.,2010) |
| Escin IIIa, IIIb, IV, V, VI | A. hippocastanum (Shiyou Li et al.,2010) |
| Isoescin Ia, Ib, V | A. hippocastanum, A. turbinata (Shiyou Li et al.,2010) |
| Deacetylescin Ia, Ib, IIa, IIb | A. turbinata (Shiyou Li et al.,2010) |
| Desacylescin I, II | A. turbinata (Shiyou Li et al.,2010) |
| Isoescin VIa, VIIa, VIIIa | A. turbinata (Shiyou Li et al.,2010) |
| Compound |
Source Species |
| Aesculioside A - H | A. chinensis (Shiyou Li et al.,2010) |
| Aesculioside Ia - Ie | A. pavia (Shiyou Li et al.,2010) |
| Aesculioside IIa - IIk | A. pavia (Shiyou Li et al.,2010) |
| Aesculioside IIIa - IIIf | A. pavia (Shiyou Li et al.,2010) |
| Aesculioside IVa - IVc | A. pavia (Shiyou Li et al.,2010) |
| Assamicin I - VIII | A. assamica (Shiyou Li et al.,2010) |
| Aesculiside A, B | A. indica, A. chinensis (Shiyou Li et al.,2010) |
| Compound |
Source Species |
| Aesculaxanthin (& isomers) | A. hippocastanum, A. pavia (Shiyou Li et al.,2010) |
| Capsanthin (& 5,6-epoxide) | A. turbinata, A. pavia (Shiyou Li et al.,2010) |
| Capsorubin | A. turbinata, A. pavia (Shiyou Li et al.,2010) |
| Neolutein C | A. hippocastanum (Shiyou Li et al.,2010) |
| Violaxanthin (& 9-cis) | A. hippocastanum (Shiyou Li et al.,2010) |
| Beta-Cryptoxanthin | A. hippocastanum (Shiyou Li et al.,2010) |
| Beta-Citraurin | A. hippocastanum (Shiyou Li et al.,2010) |
| Neochrome | A. hippocastanum (Shiyou Li et al.,2010) |
| Compound |
Source Species |
| Umbelliferone | A. hippocastanum (Shiyou Li et al.,2010) |
| Chikhorin | A. hippocastanum (Shiyou Li et al.,2010) |
| Multinoside A | A. hippocastanum (Shiyou Li et al.,2010) |
| Multiflorin B | A. hippocastanum, A. chinensis (Shiyou Li et al.,2010) |
| Aescuflavoside (& A) | A. chinensis (Shiyou Li et al.,2010) |
| Pavietin | A. pavia (Leaf) (Shiyou Li et al.,2010) |
| Distichin | A. pavia (Shiyou Li et al.,2010) |
| Trifolin | A. chinensis (Shiyou Li et al.,2010) |
| Tianshic Acid | A. chinensis (Shiyou Li et al.,2010) |
| Wilsonic Acid | A. chinensis (Shiyou Li et al.,2010) |
| Cyclopropane amino acids | A. parviflora (Shiyou Li et al.,2010) |
Bark:
"The bark of Aesculus hippocastanum, in common with the seeds, has been described as
containing the saponin mixture ‘escin’ 3. Coumarin glycosides, including esculin,
scopolin and fraxin, and their respective aglycones, esculetin, scopoletin and fraxetin, are
also present in the bark of A. hippocastanum (Figure 4), in contrast to seed tissues, in
which these compounds have not been detected. The flavonoid glycoside quercitrin (Figure
2), and its corresponding aglycone have also been detected in bark tissues. Additional
compounds, including allantoin, sterols, leucocyanidin, leucodelphinidin, catechol tannins
and alkanes have also been described as occurring in bark tissues. 3" (wilkinson1999)
Leaves:
"In common with the bark of A. hippocastanum, leaf tissues contain the coumarin
glycosides scopolin, fraxin and esculin (Figure 4) [3]. A range of flavonoid glycosides
of quercetin (e.g. quercitrin, rutin, isoquercitrin and quercetin 3-arabinoside) and the
corresponding glycosides of kaemperfol have also been detected in leaf tissues (Figure 2).
In addition to these glycosides, escin has been detected (but only in trace amounts), as well
as leucanthocyans, cis,trans-polyprenols, amino acids, fatty acids and sterols (sitosterol,
stigmasterol and campesterol)." (wilkinson1999)
- Triterpene saponins [PDR]
- Hydroxycoumarins: "chief component is aesculin, in addition fraxin and scopolin" [PDR]
- Flavonoids: "including rutin, quercitrin, and isoquercitrin" [PDR]
- Tannins [PDR]
"Twenty-one carotenoids have been identified from Aes-
culus. An early investigation on the leaves and pollen of the
three species A. turbinata, A. pavia, and A. parviflora by
HPLC analysis indicated the presence of seven carotenoids
β-carotene (162), zeaxanthin (163), α-carotene (167), lutein
(168), capsanthin (176), capsanthin 5,6-epoxide (177), and
capsorubin (178) [74]. A high concentration of α-carotene
was found in the leaves and keto hydroxyl carotenoids with a
pentanuclear ring structure (capsanthin, capsanthin 5,6-
epoxide, and capsorubin) were identified in the pollen. These
keto hydroxyl carotenoids were proposed to have special
chemotaxonomic significance for the genus Aesculus. Later,
in 2000, 16 carotene derivatives were detected in buds, pol-
len, and petals of A. hippocastanum and A. pavia by HPLC
analysis with a diode array detector utilizing authentic sam-
ples as the references. These carotenoids are β-carotene
(162), β-cryptoxanthin (164), violaxanthin (165), 9-cis-violaxanthin (166), lutein (168), 13-cis-13'-cis-lutein (169),
lutein 5, 6-epoxide (170), neolutein C (171), β-citraurin (172),
aesculaxanthin (173), 9-cis-aesculaxanthin (174), 13-cis-aes-
culaxanthin (175), 9'-cis-neoxanthin (179), 9-cis-9'-cis-neox-
anthin (180), neochrome (181), and luteoxanthin (182) [75]." (Shiyou Li et al.,2010)
Seed Phytochemicals
"Horse-chestnut seeds, as all others seeds, are natural
products whose chemical composition is a very complex
matrix. They contain a lot of different molecules and analytes, the majority of which are polysaccharides (both
starches and non-starches), proteins, lipids, mineral salts and many minor components among others, with
homogeneous or localised distributions in different districts, all
strongly interacting with each other in a synergistic way
to form very complex structures." (baraldi2007)
"A number of other products have been
isolated from chestnut seeds, i.e., coumarin derivatives (aesculin,
fraxin, scopolin), essential oils (oleic acid, linoleic acid), and
tanins (leucocyanidine, proanthocyanidin A2) (4)." (kapusta2007)
"It is interesting that different organs of this species contain
distinctive classes of the main bioactive principle: aescin in the
seeds, essential oils in the leaves, and flowers and coumarins
in the bark." (kapusta2007)
"For completeness, our experimental data about the com-
position of common Mediterranean horse-chestnuts, can
be compared with some literature values reported by Par-
mar and Kaushal (1982), even though they worked with
Aesculus indica seeds from fresh fruits. Aesculus indica is
a very common botanical species and largely diffused in
Himalayan forests, also pertaining to Hippocastanaceae
family, with some distinctive features and characters from
each others.
Probably, this comparison can result in a limited useful-
ness because of different uses of AHP or AHH and Aescu-
lus indica seeds, being the latter foodstuff still largely
consumed by local populations of Himachal Pradesh
region. Starch of seeds (about 40% on fresh fruits, with a
ratio amylopectin:amylose =/~3:1) was recommended as
famine food for extending bread flour (or other uses), after
removal of bitter characters." (baraldi2007)
- "...powdered hydroalcoholic extracts of the seeds contain 16 to 20 percent triterpene glycosides (a class of saponins), calculated as aescin (escin). Aescin... is believed to be the main active constituent of horse chestnut seed extract (Schulz, Hänsel, and Tyler, 2001)." [Barrett HCTHR]
- "Triterpene saponins (3-5%): The triterpene saponine mixture known as aescin (also escin) consists of diacylated tetra-and pentahydroxy-beta-amyrin compounds...." [PDR]
- Flavonoids: "in particular biosides and triosides of the quercetins" [PDR]
- Oligosaccharides: "including 1-kestose, 2-kestose, stachyose" [PDR]
- Polysaccharides: "starch (50%)
- Oligomeric proanthocyanidins, condensed tannins: (only in the seed-coat)" [PDR]
- Fatty oil (2-3%) [PDR]
"Seeds of A. hippocastanum have also been described as containing starch (40–50% weight)
[6], sugars, proteins (specifically the globulin, hippocastanine, containing L-(1)lysine and
L-(1)-tryptophan), a fatty oil (containing oleic, linoleic, linolenic, stearic and palmitic
acids) and purines (adenosine, adenine and guanine). [5]" (wilkinson1999)
"The saponins present in these seeds render them very
bitter, disagreable and unedible for humans. On the con-
trary, they can be consumed for human uses after removing
the bitterness of grounded flour, by soaking it in water for
about 12 h. The bitter components get dissolved in water
and removed when the water is decanted. The remaining
slurry can be destined for cuisine manipulations, and is
generally taken as a non-cereal-starch food. As reported
by Parmar and Kaushal (1982), the Aesculus indica seeds,
which constitute the edible portion of the fresh fruits, con-
tain about 50.5% moisture. The total sugars content is
5.58% (11.0% on dry matter basis), combining the reducing
(4.59%) and non-reducing sugars (0.94%), respectively. The
protein and mineral contents are 0.388% and 1.934%,
respectively, on fresh samples, that become 0.768% (pro-
teins) and 3.83% (minerals) on dry samples. Therefore,
we can assert that Aesculus indica seeds are less proteinic
and less glucidic with respect to AHP and AHH seeds sam-
ples here tested." (baraldi2007)
"Coumarins isolated from Aesculus usually have simple
structures." (Shiyou Li et al.,2010)
"The seeds of Aesculus also contain a number of long fatty
chain compounds." (Shiyou Li et al.,2010)
Aescin (Seeds)
"The principal extract and medicinal constituent of Aesculus hippocastanum
(horse chestnut) seed is aescin, a mixture of triterpenoid saponin glycosides.
It can be fractionated into beta-aescin, an easily crystallizable mixture, and
alpha-aescin, which is water-soluble." [HPEP]
"The total saponin content of seeds, often expressed as ‘(a)escin’ (Figure 1), actually
consists of α-escin and β-escin, the latter of which is, in turn, composed of more than 30
derivatives of the triterpenoids, protoaescigenin and barringtogenol C. These compounds
are primarily found in the seed cotyledons (they can constitute up to 28% of the weight of
the dry seeds), but have also been detected in the seed integument, the bark, buds, leaves
and the immature fruit pericarp of A. hippocastanum [5]." (wilkinson1999)
"Aescin is fairly soluble in water but is poorly soluble in lipid solvents." [Schulz RP]
"CAN cautions that aescin is nephrotoxic. Side effects include GI disturbance, impaired liver
function, mild nausea, shock, spasm, urticaria, and vomiting. Should be avoided by patients on
blood-thinning therapy, with hepatic or renal impairment, or lactating or pregnant. Large doses of
saponins can be fatally hemolytic in animals. LD50s range for aescin from 134 to 720 orally in
mice, rats, and guinea pigs. On ipr administration, the total saponin fraction (LD50 = 46.5 mg/kg
ipr mouse) was less toxic compared to isolated aescin (LD50 = 9.5 mg/kg ipr mouse) (CAN). LD50
of seed extract 990 mg/kg orl mouse, 2150 orl rat, 1530 orl rbt, 130 orl dog."[HMH Duke]
Flavonoids (Seeds)
"Flavonoids and their derivatives are also one of the main
components of the genus Aesculus. A total of 49 flavonoids
including flavonols and their glycosides (100-126),
flavanones, and flavanone derivatives (127-148) were iso-
lated and identified from the seeds of Aesculus." (Shiyou Li et al.,2010)
"In the present work, the main flavonoids from horse chestnut seeds were isolated and their structures established with
spectral methods. Seven glycosides were isolated, out of which six (2, 3, 4, 7, 11, 13) were previously reported and one (9)
was identified as a new tamarixetin
3-O-[β-D-glucopyranosyl(1→3)]-O-α
-D-xylopyranosyl-(1→2)-O-β-D-glucopyranoside." (kapusta2007)
"Thirteen compounds could be identified in the profile, out of
which di- and triglycoisdes of quercetin and kaempferol were the dominant forms and their acylated
forms occurred in just trace amounts. The total concentration of flavonoids in the powdered horse
chestnut seed was 0.88% of dry matter. The alcohol extract contained 3.46%, and after purification
on C18 solid phase, this concentration increased to 9.40% of dry matter. The flavonoid profile and
their content were also measured in the horse chestnut wastewater obtained as byproduct in industrial
processing of horse chestnut seeds. The total flavonoid concentration in the powder obtained after
evaporation of water was 2.58%, while after purification on solid phase, this increased to 11.23% dry
matter. It was concluded that flavonoids are present in a horse chestnut extract in a relatively high
amount and have the potential to contribute to the overall activity of these extracts. Industrial horse
chestnut wastewater can be used to obtain quercetine and kaempferol glycosides for cosmetic,
nutraceutical, and food supplement industries." (kapusta2007)
"In the present research, we also studied the flavonoid profile
and concentration in the powder obtained after evaporation of
water from horse chestnut wastewater (WWHC). The large
volume of WWHC remains in the process of precipitation of
aescin from the horse chestnut extracts. This is waste byproduct
still containing some amount of saponins and flavonoids, which
can be commercially useful." (kapusta2007)
"The flavonoid profile of WWHC was identical to the profile
of HCE, with the total concentration of 2.54% dry matter.
One-step purification of this fraction on the solid phase
produced WWHCF, the product with flavonoid concentration
of 11.23% dry matter. This has been a quite high amount,
and the product can have commercial value. It can be used
in the pharmaceutic, cosmetic, and food industries. Eleven
percent concentration of flavonoids makes the product an
attractive source for the nutraceutic industry as a high-flavonoid supplement. As shown above, horse chestnut
flavonoids are the mixture of quercetin and kaempferol
glycosides, the most desired flavonoids in our diet due to
their antioxidant activity. Quercetin and kaempferol were
documented to be the most potent antioxidant of all flavonoids, (10) and their daily consumption is estimated to be
about 25 mg per day (11). Further increase of this amount
in the diet can be obtained by flavonoid supplementation,
and WWHCF can be a good source of this. The economic
evaluation of this source should be performed. It seems
logical that the WWHC, instead of being dried and powdered,
can be simply passed through a solid-phase column (reversed-phase C18 or Amberlite XAD4), which retains flavonoids
and lets saccharides and other strongly polar components of
the WWHC matrix go through." (kapusta2007)
"It can be concluded that the flavonoid content in horse
chestnut seed seems to be high enough to contribute to overall
activity of the extracts. The high content of flavonoids in
industrial horse chestnut wastewater and the ease of their
condensation and purification makes this byproduct a promising
source of quercetin and kaempferol glycosides to be used in
the cosmetic and food additive-producing industries." (kapusta2007)
"Nine flavonol oligosides of quercetin and kaempferol with glucose, xylose, and rhamnose as sugars were isolated
from the seeds of Aesculus hippocastanum L. (Hippocastanaceae). Five of them are new compounds (2 trisaccharides,
1 bisdesmoside, a nicotinic and a indolinone hydroxyacetic acid ester of the bisdesmoside)." (Hubner,1999)
"Extracts of the seeds of Aesculus hippocastanum L. (horse chestnut; Hippocastanaceae) are widely used to successfully treat chronic
venous insufficiency (1), (2). The main active constituent is considered to be aescin, a mixture of several saponin esters of the
oleanane type (1), (3). However, some authors believe that the flavonoids contribute to the observed activity of horse chestnut
seed extracts (3), (4)." (Hubner,1999)
"The partial lack of knowledge about the polyphenolic fraction of this widely used crude drug has led to the following re-examination
of the flavonoids of the seeds of A. hippocastanum." (Hubner,1999)
"A quantitative determination of the flavonoids according to Betulae folium of the
European Pharmacopoeia (1997) gave a total flavonoid content of 0.29% (calculated as rutin)." (Hubner,1999)
"In conclusion, the seeds of A. hippocastanum contain a series of quercetin and kaempferol di- and triglycosides, some of which
have unusual acyl substituents. The overall content of ca. 0.3% (calculated as rutin) is low. Hence, a contribution of the
flavonol glycosides to the therapeutic efficacy of the crude drug seems unlikely." (Hubner,1999)
Sugars (Seeds)
"The values obtained for total glucides content in these
natural products was in the range 14.3% (AHH)–15.2%
(AHP). As previously mentioned in the experimental sec-
tion, our analysis methodology permit us to determine
the two most important monosaccharides (and appar-
ently, the only species in these matrices), such as glucose
and fructose. However, we observe that while glucose
concentration is almost the same on the two sample
groups (6.8% for AHP and 6.9% for AHH), fructose con-
tent is well differentiated (8.4% for AHP and 7.4% for
AHH).
Actually, we are unable do determine the presence of
other sugars, such as the most common sucrose (the disac-
charide based on glucose and fructose condensation). Nev-
ertheless, we are obliged to mention that, generally, edible
chestnut seeds mainly contain sucrose (about 10–30%), and
only few traces of free monosaccharides (about 0.1–0.5%)
(De La Montana Miguelez et al., 2004)." (baraldi2007)
Fatty Acids (Seeds)
"Therefore, the aims of this work were to study some
characters of chemical composition and the relevant classi-
fication of seeds from two most wide spread varieties of
Aesculus hippocastanum L., such as pure species, with white
flowers (AHP), and a common hybrid species with pink
flowers (AHH). Both these common Hippocastanum trees
are growing in the mediterranean regions, and their luxuri-
ous summer flowering is very showy." (baraldi2007)
"Lipids represent a significant fraction on these original
products (4–5% of the dry mass)" (baraldi2007)
(baraldi2007)
Epicuticular Leaf Waxes
"Ae. hippocastanum leaves (102 g) contained an
extractable epicuticular wax (241 mg) of about
0.63% dry wt., which calculated for 22 µg wax per
cm2 leaf surface area or 4540 µg wax per one leaf.
This wax of mature leaves consisted, like the wax
of C. sativa (Castanea sativa), of homologous series of wax lipids
and in addition greater amounts of triterpenoids
(54% of the wax). Main lipid classes are aldehydes
(13%), fatty acids (8 %), primary alcohols (7%),
wax esters (7%), hydrocarbons (5%) and additionally acetates (5%). Composition and yield of
the individual lipid classes are listed in Table I. The
compositions of the homologous series are summarized in Table II.
All these lipid classes have the same chain
lengths as found for C. sativa and show no main
component dominating. The distribution patterns
of these lipids are therefore very even.
Triterpenols were found to be the dominating
wax compounds. ß-Amyrin, a-amyrin and lupeol
were again predominant in a relative ratio of
3:2.2:2.2. These triterpenols were present also
esterified with fatty acids (2% of the wax). Furthermore, friedelanol and friedelanone were identified by GC-MS and comparison with authentic
samples [6 , 7]. The latters were found in concentra
tions of about 1.5% of the wax, each...." (P.-G. Gülz et al.)
"The SEM figures of mature leaves of Ae. hippocastanum show no trichomes on the abaxial as well
as on the adaxial epidermis. Both leaf surfaces are
characterized by numerous cuticular lamellae
(Fig. 2, A and B). The cuticular lamellae are found
to be linear (Fig. 2,C) and also wavelike
(Fig. 2, D). All epidermal cells are covered with a
continuous wax layer without any wax sculptures
or crystalloids. After washing the leaves with chloroform all wax was extracted. The remaining cuti
cular lamellae are clearly visible on the abaxial and
adaxial epidermal cells...." (P.-G. Gülz et al.)
"C. sativa and Ae. hippocastanum are systemati
cally not very closely related plant genera. However, they have a rather similar wax composition.
They contain the same homologous series of wax
lipids, but with individual distribution patterns.
No one of these lipid classes has one main component dominating. In addition to the wax lipids,
both plant waxes contain mixtures of triterpenols.
In C. sativa wax ß-amyrin, a-amyrin and lupeol
are found. In Ae. hippocastanum wax the same triterpenols are analyzed and additionally friedelanol
and friedelanone. Both leaf waxes contain wax
lipids and triterpenols with no main component in
a dominating concentration. Therefore, wax crystalloids on the leaf surfaces of these two plants are not expected." (P.-G. Gülz et al.)
Folkore
"The common name "horse chestnut″ may have come from
the uses of seeds for horses to treat overexertion or coughs
by Turks and Greeks [18]. Dated from the early 18th century,
the horse chestnut has a therapeutic property for anti-fever
[5]. In Europe, the bark and leaves of A. hippocastanum have
been employed as an astringent to treat diarrhea and hemor-
rhoids [6]." (Shiyou Li et al.,2010)
- The drug is generally provided by the ripe seed, as described in German and Spanish pharmacopeias, while Portuguese pharmacopeia also includes the bark. [Bajaj MAPS 7]
- Some kind of horse chestnut decoction was drunk in Essex for lumbago, spoken of there as rheumatism (Newman & Wilson)." [DPL Watts]
- "Elsewhere, including Spain (H W Howes), it is piles that is reckoned to be cured or prevented by carrying them around (W B Johnson; Tongue; Fogel), and that is interesting, because it is known that extracts of horse chestnut are rich in Vitamin K, and so is useful in treating circulatory disorders like piles, varicose veins and chilblains (Conway)." [DPL Watts]
- "A fluid extract made from the nuts is also used to protect the skin from the harmful effects of the sun (Schauenberg & Paris)." [DPL Watts]
- "Another usage of conkers was as a snuff to cure catarrh and headache. The Pennsylvania Germans used it that way (Fogel), but this was quite an early habit (see Thornton), and the idea was to grate them up and use the powder to make one sneeze. Apparently it was recommended not only as a powder but also as an infusion or decoction to take up the nostrils. The leaves and flowers have occasionally been used, too (and so has the bark)." [DPL Watts]
- "The leaves are narcotic; an infusion of them has been used for insomnia(Conway)" [DPL Watts]
- "A tincture of the flowers is sometimes given for rheumatism (Perry. 1972)." [DPL Watts]
- "The bark has been used for fevers, and externally, for ulcers (Wickham)" [DPL Watts]
- Several French works published between 1896 and 1909 reported successful outcomes in the treatment of hemorrhoidal ailments. [Schulz RP]
"The bark is no longer in common
use, but has a folk medicinal application as a febrifuge, and as an astringent in cases of
diarrhoea and haemorrhoids [4]. Decoctions of the bark are also used, albeit rarely, for the
topical treatment of skin disorders, such as sores, lupus and ulcers [4]. The bark has also
previously been used as an anti-malarial agent, as a cinchona substitute, but this practice
is no longer continued [3]. Horse chestnut leaf preparations are used in folk medicine to
treat coughs, rheumatism and arthritis, although the underlying phytochemical basis for
these applications has not been determined [3]." (wilkinson1999)
Cultivation
"Prefers a deep loamy well-drained soil but is not too fussy tolerating poorer drier soils[11, 200]. Tolerates exposed positions and atmospheric pollution[200]. A very ornamental and fast-growing tree[1, 4], it succeeds in most areas of Britain but grows best in eastern and south-eastern England[200]. Trees are very hardy when dormant, but the young growth in spring can be damaged by late frosts. The flowers have a delicate honey-like perfume[245]. Trees are tolerant of drastic cutting back and can be severely lopped[200]. They are prone to suddenly losing old heavy branches[98]. The tree comes into bearing within 20 years from seed[98]. Most members of this genus transplant easily, even when fairly large[11]. Special Features: Attractive foliage, Not North American native, Naturalizing, Blooms are very showy."[PFAF]
"Presowing treatment of seeds with cobalt nitrate increased drought resistance of horse chestnut
(Aesculus hippocastanum L.) from the Donets Basin in southeastern Europe (87)." [Barker HPN]
"In conclusion, our results suggests that in horse-chestnut, where natural variation is large and vegetative
propagation through natural cross-hybridisation and grafting is
very easy, the traditional method of selection variety may
give good results in terms of selected fruits and seeds productions, also in relation to the optimisation procedures
for technological transferability, and to obtain the best performances for
bio-available supplements and specific salutary targets." (baraldi2007)
A single exotic pathogen that has appeared in Europe in the last decade, has
devastated the European horse chestnut (Aesculus hippocastanum). "Trees were
observed to be suffering from a new form of bleeding canker on their stems which
ultimately kills them, firstly in continental Europe and more recently across the
UK as well.
The causal agent of the disease was identified as a new species of pathogenic
bacterium; Pseudomonas syringae pv. aesculi. It is thought that this bacterium
originated in India on the Indian horse chestnut, and was probably introduced to
Europe via the plant trade (as highlighted by Brasier 2008).... results have shown that there is only one strain of this organism
across the whole of Europe, which suggests that the outbreak is probably the result
of a single introduction event." [Fenning COWF]
"...A. hippocastanum could be suggested as an appropriate biomonitor for Pb atmospheric pollution, and for Cu in highly polluted areas." [Anicic, 2011]
Propagation
"Seed - best sown outdoors or in a cold frame as soon as it is ripe[11, 80]. The seed germinates almost immediately and must be given protection from severe weather[130]. The seed has a very limited viability and must not be allowed to dry out. Stored seed should be soaked for 24 hours prior to sowing and even after this may still not be viable[80, 113]. It is best to sow the seed with its 'scar' downwards[130]. If sowing the seed in a cold frame, pot up the seedlings in early spring and plant them out into their permanent positions in the summer."[PFAF]
"Propagation is generally by seed, which fall in autumn, remain dormant over
winter, and germinate in spring, at least in Liguria (Italy). In the first year plants
have either two or four leaves. The vegetative growth of such plants returns the
following year. The plant may also be propagated by cutting; in this case the
specimens have the same morphological and physiological characteristics as the
parent plant." [Bajaj MAPS 7]
Bioaccumulation
"The mean concentrations of heavy metals (Pb, Cd, Zn and Cu) in the unwashed and
washed leaves, bark and soils of A. hippocastanum from different sites are presented.... A comparison of concentrations of
heavy metals in the leaves, barks and soils reveals that the values in the urban roadside
are higher than other sites due to higher human activity and higher vehicular traffic. A
similar finding is reported by Tam et al. (1987) from Hongkong who found a significant
correlation between traffic density and Pb, Cu and Zn concentrations. The heavy metal
concentration in the bark and soils are higher than in the leaves as in our findings." (Yilmaz,2006)
"The highest lead concentration was found in the urban roadside soils (6.745 µg g-1)
as compared to the suburban soils (0.812 µg g-1)....In the A. hippocastanum leaves the highest values of lead in the urban
roadside samples (0.119 µg g-1),....Lead concentration of the bark too as expected was high in the urbanroadside samples (0.628 µg g-1)," (Yilmaz,2006)
"The Cd values
in our samples in general are very low, but highest values were recorded in the urban
roadside unwashed samples (0.068 µg g-1). The values for unpolluted natural
environments should lie between 0.01-0.03 µg g-1 (Allen, 1989)....The reason for the low values could be due to a low
atmospheric deposition in this region because of long lasting rainy season." (Yilmaz,2006)
"In A. hippocastanum the Zn concentrations measured during this study were
between 0.374 - 0.532 in the washed leaves, 0.391-0.591 in the unwashed leaves, 0.406-
0.660 in the bark and 2.196 and 4.598 µg g-1 in soil....By following the Zn pollution criteria levels of Dmuchowski and
Bytnerowicz (1995), we can conclude that Thrace region does not show Zn pollution....In the uncontaminated soils, the total Zn
content is said to lie between 10-300 µg g-1 (Freedman & Hutchinson, 1981). In these
soils, total Zn is constant in the soil profile, but extractable Zn generally decreases with
depth because of decrease in organic matter. The higher amount of the Zn in our soils can
be attributed to the high organic matter content." (Yilmaz,2006)
"The soil Cu can vary greatly among the sites at the same location and in
different locations. The Cu values of soil samples supporting A. hippocastanum lie
between 0.5171 and 1.1165 µg g-1,in the unwashed leaves Cu content ranges between
0.322-0.466, in the washed leaves between 0.256 and 0.387 and in the bark between
0.3451-0.117 µg g-1. In normal uncontaminated soils Cu content varies between 2-100 µg
g-1 (Freedman & Hutchinson, 1981). Our values are low."
"Washing the leaves significantly reduced the lead, cadmium, zinc and copper
concentrations. The reduction for the lead was 57.14 percent for the urban roadside,
27.66 for the city centre and 13.04 for the suburban area, whereas for cadmium these
values were 97.06, 50.0 and 0.0 % respectively. In the case of zinc the reduction was
10.43 % in the urban roadside, 3.36 % in the city centre and 4.35 % in the suburban
areas, and for copper it was 16.95 % in the urban roadside, 17.39 % in the city centre and
20.50 % in the suburban areas. The percentage removal was the highest in the urban
roadside (57.14 %) as compared to suburban. The reason for this is differences in the
atmospheric deposition of these metals and high and low traffic densities. This data
coincides with that of Al-Shayeb et al. (1995) who reported a removal of 26-68 % of Pb
by washing." (Yilmaz,2006)
"The atmospheric deposition of heavy metals in the present study area is
not very high, the concentration of heavy metals in A. hippocastanum did not exceed the
upper limit." (Yilmaz,2006)
"The regression analysis data shows (Fig. 6) that our values for soils and plants are
significant for Pb, Zn and Cu, but not for Cd. We can thus conclude that with an increase
in the amount of the heavy metals in the soil, their uptake by plants also increased." (Yilmaz,2006)
"A. hippocastanum
is widely distributed in Europe and is used as a roadside ornamental tree. In accordance
with the data presented here this tree possesses all the characteristics for its selection as a
biomonitor." (Yilmaz,2006)
"This study gives an evidence for the seasonal accumulation of
Cr, Fe, Ni, Zn, and Pb in leaves of A. hippocastanum and Tilia spp.
(except Zn) sampled in the Belgrade urban area. During the studied time span, Pb concentrations in the leaves showed a decreasing
trend (more regular for A. hippocastanum), being in accordance to
the bulk atmospheric deposition data. Also, the temporal concen-
tration trend for the Cu in A. hippocastanum was decreasing and in
accordance with the Cu trends in the bulk atmospheric deposition
at the site with the highest atmospheric Cu loading. No agreement
was observed between the accumulation trend of Cr, Fe, Ni, and Zn
in leaves and the bulk deposition rates, i.e. the elements content in
the leaves did not reflect atmospheric deposition directly.
Accordingly, A. hippocastanum could be suggested as an appropriate biomonitor for Pb atmospheric pollution, and for Cu in highly
polluted areas." (Anicic,2011)
"The concentrations of cadmium, copper, lead and zinc
have been measured in the leaves of a deciduous tree the
horse chestnut (Aesculus hippocastanum L.) over the
period of their lifetime (7 months). The average concen-
trations for the total sample based on ash weight are."
(txg g l) cadmium, 0.197; copper, 129; lead, 294; and
zinc, 299. The temporal trends in the concentrations of
the metals can be related to their dominant source. Cop-
per and zinc concentrations are highest in the new leaves
and decrease with time, suggesting the main source of the
elements are uptake from the soil. The decrease occurs
partly because of dilution by leaf material as it increases
over the growing period. In the case of zinc, however,
aerial deposits appear to be also a significant source.
Lead concentrations, on the other hand, show an increase
with time, which can be related to increasing deposits
from aerosol lead arising from the combustion of petrol
lead. The increase is enough to offset the dilution effect.
For cadmium there is no significant trend, but the ten-
dency is a decrease with time. It is not possible, however,
to distinguish between soil uptake and aerial deposit as
both are small compared with increase in leaf material." (kim1994)
"The measure of the maturity of the leaves in terms of
the amount of internal consolidation ( g c m 2) is lowest
in samples collected when the leaves first opened, and
increases steadily until January-March. Ash weight
concentrations of copper and zinc show the opposite
trends, and decrease (in a non-linear manner) with the
age of the leaves. Highly significant negative correla-
tions between the variable ( g c m -2 x 105) and the con-
centrations of copper and zinc suggest that growth of
the leaves causes dilution in the concentrations of cop-
per and zinc, but also there may be some loss of the
metal ions out of the leaves. Growth of the leaves may
account for about 60--70% of the reduction in copper
and zinc concentrations with time." (kim1994)
"The fact that copper and zinc concentrations are
highest when the leaves first open implies that these
metals are primarily derived from the soil and that
most of the copper and zinc is translocated into the
leaves prior to their unfolding. In the case of zinc, how-
ever, as the leaves grow an atmospheric contribution
becomes important, offsetting to some extent the dilu-
tion due to leaf growth. The association of copper and
zinc with developing leaves is probably a result of the
roles that these two metals have in plant protein and
carbohydrate metabolism." (kim1994)
"Ash weight lead concentrations are lowest when the
leaves first appear, and increase in a linear (and highly
significant) manner with the age of the leaves. The
source of this lead is likely to be petrol combustion,
and it is probable that direct deposition of the lead-rich
aerosols on the leaves (rather than translocation of lead
from the roots) is the predominant enrichment path-
way. The rate of lead accumulation is sufficient to
negate any dilution effect that might be caused by leaf
growth." (kim1994)
"No clear (statistically justified) trend is evident which
links cadmium concentrations in horse chestnut leaves
with the age of the leaves. Additionally, cadmium con-
centrations in the leaves are uncorrelated with those of
copper, lead or zinc. However, a 'very significant' nega-
tive correlation between cadmium concentrations and
the variable (g cm 2 x 10 5) suggests that growth of the
leaves may cause some dilution in cadmium concentra-
tions. It is possible that, if cadmium is accumulating
on/in the leaves, the rate of this accumulation is suffi-
cient to partially compensate for the dilution effect
caused by the leaves growing. Unlike the results for
copper, lead and zinc, the results for cadmium do not
clearly identify probable sources or enrichment path-
ways of that metal to leaves." (kim1994)
"Leaves collected from the three sites situated near
main roads (sites 1, 4 and 5) have statistically more
cadmium, copper, and lead than leaves collected from
the other sites, implying that traffic is a source of cad-
mium, copper and lead to horse chestnut leaves. The
atmospheric source of zinc may derive from weathering
of galvanised iron roofs, which are relatively common
in New Zealand." (kim1994)
AESCULUS BUCKEYE
"Large shrub or tree. Leaf: palmate, leaflets 5–7[9]. Flower: petals 4[5], >> sepals. Fruit: capsule leathery. Seed: 1, large.
± 15 species: northern hemisphere. (Latin name for a sp. of oak)" [Jepson]
Local Species;
- Aesculus hippocastanum - Horse-chestnut [Cultivated]
"Aesculus L. is a genus of the family Hippocastanaceae
containing 12 species of deciduous trees and shrubs in the
northern hemisphere, primarily in eastern Asia and eastern
North America, with one species native to Europe, and two
to western North America [1-4]." (Shiyou Li et al.,2010)
"Aesculus hippocastanum has been cultivated since
1576 as an ornamental plant [17] while A. chinensis var.
chinensis has been planted in temples and homes for several
centuries. At present, all species are cultivated, with at least
27 commercial cultivars supplied by at least 95 nurseries in
the United States [17]." (Shiyou Li et al.,2010)
"There are two Eurasian species commonly used in medicine: A. hippocastanum
(common horse chestnut) and A. chinensis var. chinensis
(Chinese horse chestnut)." (Shiyou Li et al.,2010)
"To date, over a hundred species or varieties in Aesculus
have been described because of great morphological variations due to natural pollination among the species. In his
monograph of Aesculus, Koch (1857) recognized 13 species
in four subgenera, Hippocastanum, Pavia, Calothyrsus, and
Macrothyrsus [12]. Based on bud viscidity, fruit exocarp
ornamentation, flower color, and petal morphology, the 13
species were grouped into five sections [1, 2, 13]. All new
species discovered in the last several decades are not recognized and thus most authors recognized 13 species in the
genus until A. wilsonii Rehder was recently treated as a variety under the species A. chinensis Bunge [3, 14]. The 12
currently recognized species in the genus Asculus are
grouped in the five sections...." (Shiyou Li et al.,2010)
Chemotaxonomy
"....Some chemotaxonomical analysis has been conducted [15]. Interestingly, A. pavia in the Section Pavia has tritepernoid saponins
with an oligosaccharide chain at C-3 of the aglycone with an
α-arabinofuranosyl unit affixed to C-3 of the glucuronic acid
while Eurasian species in Section Aesculus and Section Calothyrsus have saponins with a trisaccharide chain at C-3 of
the aglycone with a β-glucopyranosyl unit attached to C-4 of
the glucuronic acid [16] (see Triterpenoid Saponins for details). This significant chemical difference suggests that
triterpenoid saponins may provide important clues in understanding the systematics and evolution of the genus Aesculus." (Shiyou Li et al.,2010)
Use of Related Sp.
"Seeds of North American species (e.g., A. pavia, A. flava,
A. glabra, and A. californica), known as buckeyes, were
used by Native Americans to tranquilize fish to make them
easier to catch [22]. Extracts from the seeds were used to
treat earaches, sores, colic, sprains, and chest pains [23].
Powdered bark was sometimes used to alleviate toothaches
and ulcer pain [24]." (Shiyou Li et al.,2010)
"The genus Aesculus has 12 species, but only A. hippocas-
tanum and A. chinensis var. chinensis, two Eurasian species,
are officially recognized sources of herbal products in tradi-
tional medicine. HCSE or aescin from A. hippocastanum has
shown satisfactory evidence for clinically significant activity
in chronic venous insufficiency, hemorrhoids, and post-
operative oedema, largely due to its anti-inflammatory prop-
erties, which were well demonstrated by in vitro and in vivo
assay. However, the mechanism of action of the Chinese
horse chestnut is poorly understood and further investigation
is necessary." (Shiyou Li et al.,2010)
Aesculus californica - California buckeye
"Nuts processed into mush and served with pit oven-cooked deer meat, seafood, roasted
peppernuts, and contemporary picnic foods within the living memory of Kashaya Pomo
individuals (Ortiz 1989a: 25)" (Ortiz,GTR)
"Aesculus californica (Spach.) Nutt. Berraco; chattYa (M), chatch (R). Fruits eaten, after leaching; bark
used in decoctions for toothache, loose teeth; salve of pulverized fruits applied to hemorrhoids;
fruits used in preparation of fish poison. (1)" (Bocek)
Aesculus chinensis
"In Chinese herbal medicine, the seed of a related plant, A. chinensis, is used to treat malnutrition and other
digestive difficulties at a dose of 3 to 9 grams in decoction. Japanese herbal medicine prescribes the seed of A. turbinata,
another related plant, to treat digestive difficulties and promote absorption.80" [Boik NCCT]
"In China, the seeds of A. chinensis var.
chinensis have been used as a stomachic and analgesic in the
treatment of distention and pain in chest and abdomen, malaria, and dysentery
10 and tablets made from the seeds are
also used for treating heart diseases
11."
(Shiyou Li et al.,2010)
"Aesculus chinensis is native to China and is distributed
mainly in the Hebei, Henan, and Shanxi provinces. The fruits
of this species usually are smooth subglobose, truncate to
slightly impressed at the apex, thickly walled with smaller
seeds having proportionately larger hilum. The surface of its
petiolulate leaflets is glabrous or sparingly pilose [2]. Its
seeds, called "Sha Luo Zhi" in traditional Chinese medicine,
have long been used as a stomachic and analgesic in the
treatment of distention and pain in chest and abdomen, ma-
laria, and dysentery [10]. Additionally, the tablets made from
the seeds are used for treating heart diseases [11]." (Shiyou Li et al.,2010)
Aesculus indica
Aesculus indica (Colebr. Ex. Cambess.) Hook.
"Ethnomedicinal uses: Oil from the seeds is externally applied against rheumatism. Seeds are given to
horses in colic pain." (Kumar et al.,2009)
"Aesculus indica, known as Indian horse chestnut, is
found on mountain slopes or in moist and shady valleys in
the northwestern Himalayan forests. It is distributed from
Nepal northwestward into the State of Kashmir in north India, and across the Indus River to West Pakistan and to
northeastern Afghanistan. Its fruits are reddish brown,
smooth ovoids. The petiolulate leaflets of this species are
submembranacous with finely serrate margin [2]. In some
parts of Himachal Pradesh, the seeds are dried and grounded
into flour, called tattwakhar. This flour is bitter and used for
making halwa, which is taken as phalahar (non-cereal food)
during fasts; the leaves are used as a fodder for cattle. India
horse chestnut also has medicinal properties for animals and
human beings. The fruits are given to horses suffering from
colic. The oil extracted from the seeds is used to cure rheumatism [21]." (Shiyou Li et al.,2010)
Aesculus pavia
"Recently, a new
prenylated coumarin with antifungal activity, pavietin (161),
was isolated and identified from the leaves of A. pavia [67]." (Shiyou Li et al.,2010)
Aesculus turbinata
"Aesculus turbinata, known as Japanese horse chestnut, is
native only to Japan. It has been found on the island of Hokkaido and the central and northern parts of Honshu. This
species has been widely cultured in England, the United
States, and China. This species is similar to A. hippocastanum, differently mainly in the slightly smaller flowers, warty
fruit surface, and in the larger leaves, which are glaucescent
beneath and have more regularly crenate-serrate margins [2].
The seeds of the Japanese horse chestnut have been used as
an emergency provision since ancient times and utilized traditionally in Japan as a confectionery ingredient in rice cakes
and rice balls [19]. Its seed extract in combination with spirits have also been used as a folk medicine for the treatment
of bruises and sprains in some regions of Japan [20]." (Shiyou Li et al.,2010)
"The seeds of A. turbinata also contain rich triterpenoid
saponins as the main components. A number of investigations on the seeds of Japanese horse chestnut resulted in the
isolation and structure determination of 16 polyhydroxylated
triterpenoid saponins." (Shiyou Li et al.,2010)
References
- (Anicic,2011) Aničić, M., et al. "Trace elements accumulation and temporal trends in leaves of urban deciduous trees (Aesculus hippocastanum and Tilia spp.)." Ecological Indicators 11.3 (2011): 824-830.
- (baraldi2007) Baraldi, Cecilia, et al. "Chemical composition and characterisation of seeds from two varieties (pure and hybrid) of Aesculus hippocastanum." Food chemistry 104.1 (2007): 229-236.
- (Bocek) Bocek, Barbara R. "Ethnobotany of costanoan Indians, California, based on collections by John P. Harrington." Economic Botany 38.2 (1984): 240-255.
- (chung1998) Chung, King-Thom, et al. "Tannins and human health: a review." Critical reviews in food science and nutrition 38.6 (1998): 421-464.
- Duke - http://www.ars-grin.gov/cgi-bin/duke/ethnobot.pl?Aesculus%20hippocastanum Accessed Dec 23, 2014
- E-Flora BC, E-flora - http://ibis.geog.ubc.ca/biodiversity, Electronic Atlas of the Flora of British Columbia, Klinkenberg, Brian. (Editor) 2013. E-Flora BC: Electronic Atlas of the Flora of British Columbia (eflora.bc.ca). Lab for Advanced Spatial Analysis, Department of Geography, University of British Columbia, Vancouver.
- (facino1995) Facino, Roberto Maffei, et al. "Anti‐elastase and anti‐hyaluronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: factors contributing to their efficacy in the treatment of venous insufficiency." Archiv der Pharmazie 328.10 (1995): 720-724.
- Herbs2000 - Aesculus hippocastanum, Accessed May 18, 2014
- (guarrera1999) Guarrera, Paolo Maria. "Traditional antihelmintic, antiparasitic and repellent uses of plants in Central Italy." Journal of ethnopharmacology 68.1-3 (1999): 183-192.
- (gurib-fakim2006) Gurib-Fakim, Ameenah. "Medicinal plants: traditions of yesterday and drugs of tomorrow." Molecular aspects of Medicine 27.1 (2006): 1-93.
- (Hubner,1999) Hübner, Gabriele, Victor Wray, and Adolf Nahrstedt. "Flavonol oligosaccharides from the seeds of Aesculus
hippocastanum." Planta Medica 65.07 (1999): 636-642.
- (Irving H. Isenberg) Isenberg, Irving H. "Papermaking fibers." Economic Botany 10.2 (1956): 176-193.
- Jepson2012 - William J. Stone, 2012. Aesculus, in Jepson Flora Project (eds.), Jepson eFlora, http://ucjeps.berkeley.edu/cgi-bin/get_IJM.pl?tid=12026, accessed on Mar 6 2014, January 10, 2019.
- (kapusta2007) Kapusta, Ireneusz, et al. "Flavonoids in horse chestnut (Aesculus hippocastanum) seeds and powdered waste water byproducts." Journal of agricultural and food chemistry 55.21 (2007): 8485-8490.
- (kim1994) Kim, Nicholas D., and Jack E. Fergusson. "Seasonal variations in the concentrations of cadmium, copper, lead and zinc in leaves of the horse chesnut (Aesculus hippocastanum L.)." Environmental Pollution 86.1 (1994): 89-97.
- (konoshima1986) Konoshima, Takao, and Kuo-Hsiung Lee. "Antitumor agents, 82. Cytotoxic sapogenols from Aesculus hippocastanum." Journal of natural products 49.4 (1986): 650-656.
- (Kumar et al.,2009) Kumar, Mahesh, Yash Paul, and V. K. Anand. "An ethnobotanical study of medicinal plants used by the locals in Kishtwar, Jammu and Kashmir, India." Ethnobotanical leaflets 2009.10 (2009): 5.
- (matsuda1997) Matsuda, Hisashi, et al. "Antiinflammatory effects of escins Ia, Ib, IIa, and IIb from horse chestnut, the seeds of Aesculus hippocastanum L." Bioorganic & Medicinal Chemistry Letters 7.13 (1997): 1611-1616.
- (Ortiz,GTR) Ortiz, Beverly R. "Contemporary California Indians, oaks and sudden oak death (Phytophthora ramorum)." In: Merenlender, Adina; McCreary, Douglas; Purcell, Kathryn L., tech. eds. 2008. Proceedings of the sixth California oak symposium: today's challenges, tomorrow's opportunities. Gen. Tech. Rep. PSW-GTR-217. Albany, CA: US Department of Agriculture, Forest Service, Pacific Southwest Research Station: pp. 39-56. Vol. 217. 2008.
- (P.-G. Gülz et al.) Gülz, P-G., E. Müller, and T. Herrmann. "Chemical composition and surface structures of epicuticular leaf waxes from Castanea sativa and Aesculus hippocastanum." Zeitschrift für Naturforschung C 47.9-10 (1992): 661-666.
- (Pieroni, Andrea, et al.) Pieroni, Andrea, et al. "Ethnopharmacognostic survey on the natural ingredients used in folk cosmetics, cosmeceuticals and remedies for healing skin diseases in the inland Marches, Central-Eastern Italy." Journal of Ethnopharmacology 91.2-3 (2004): 331-344.
- PFAF - Aesculus hippocastanum, Plants For A Future, http://www.pfaf.org/user/Plant.aspx?LatinName=Aesculus+hippocastanum, Accessed Jan 12, 2015
- (Podolak et al,2010) Podolak, Irma, Agnieszka Galanty, and Danuta Sobolewska. "Saponins as cytotoxic agents: a review." Phytochemistry Reviews 9.3 (2010): 425-474.
- (Redzic,2007) S Redžić, Sulejman. "The ecological aspect of ethnobotany and ethnopharmacology of population in Bosnia and Herzegovina." Collegium antropologicum 31.3 (2007): 869-890.
- (Saric-kundalic et al., 2010) Šarić-Kundalić, Broza, et al. "Ethnobotanical study on medicinal use of wild and cultivated plants in middle, south and west Bosnia and Herzegovina." Journal of ethnopharmacology 131.1 (2010): 33-55.
- (Shiyou Li et al.,2010) Li, Shiyou, Xiao-Yuan Lian, and Zhizhen Zhang. "An overview of genus Aesculus L.: ethnobotany, phytochemistry, and pharmacological Activities." (2010).
- Wiki - Aesculus hippocastanum, Wikipedia.org, https://en.wikipedia.org/wiki/Aesculus_hippocastanum
- [3] Rushforth, K. (1999). Trees of Britain and Europe. Collins ISBN 0-00-220013-9.
- [5] Euro+Med Plantbase Project: Aesculus hippocastanum Archived September 28, 2007, at the Wayback Machine.
- (wilkinson1999) Wilkinson, J. A., and A. M. G. Brown. "Horse Chestnut–Aesculus hippocastanum: Potential applications in cosmetic skin‐care products." International journal of cosmetic science 21.6 (1999): 437-447.
- (Yilmaz,2006) Yilmaz, Ruya, et al. "Use of Aesculus hippocastanum L. as a biomonitor of heavy metal pollution." Pak. J. Bot 38.5 (2006): 1519-1527.
Image References
- 1, Chestnut inflorescences (Aésculus hippocástanum), Ввласенко, CC BY-SA 3.0 , via Wikimedia Commons
- 2, Fruit de marronnier (Aesculus hippocastanum), Gzen92, CC BY-SA 4.0 , via Wikimedia Commons
Journals of Interest
- Yılmaz, R., S. Sakcalı, C. Yarcı, A. Aksoy and M. Ozturk, 2006. Use of Aesculus hippocastanum L.
as a biomonitor of heavy metal pollution. Pak. J. Bot., 38(5): 1519-1527.
- Kim, N.D., Fergusson, J.E., 1994. Seasonal variations in the concentrations of
cadmium, copper, lead and zinc in leaves of the horse chesnut (Aesculus hip-
pocastanum L.). Environ. Pollut. 86, 89–97.
- De La Montana Miguelez, J., Miguez Bernardez, M., & Garcia Queijeiro,
J. M. (2004). Composition of varieties of chestnuts from Galicia
(Spain). Food Chemistry, 84, 401–404.
- Deli, J., Matus, Z., & Toth, G. (2000). Comparative study on the
carotenoid composition in the buds and flowers of different Aesculus
species. Chromatographia, 51, 179–182.
- Deli, J., Molnar, P., Matus, Z., Toth, G., Steck, A., Niggli, U. A.,
et al. (1998). Aesculaxanthin, a new carotenoid isolated from
pollens of Aesculus hippocastanum. Helvetica Chimica Acta, 81,
1815–1820.
- Facino RM, Carini M, Stefani R, Aldini G, Saibene L: Anti-elastase
and anti-hyaluronidase activities of saponins and sapogenins
from Hedera helix, Aesculus hippocastanum, and Ruscus
aculeatus: factors contributing to their efficacy in the treat-
ment of venous insufficiency. Arch Pharm (Weinheim) 1995,
328:720-4.
- Konoshima, T., & Lee, K. H. (1986). Antitumor agents, 82. Cytotoxic
sapogenols from Aesculus hippocastanum. Journal of Natural Prod-
ucts, 49, 650–656.
- Wei, F., Ma, L. Y., Cheng, X. L., Lin, R. C., Jin, W. T., Khan, I. A., et al.
(2005). Preparative HPLC for purification of four isomeric bioactive
saponins from the seeds of Aesculus chinensis. Journal of Liquid
Chromatography and Related Technologies, 28, 763–773.
- Yang, X. W., Zhao, J., Cui, Y. X., Liu, X. H., Ma, C. M., Hattori, M.,
et al. (1999). Anti-HIV-1 protease triterpenoid saponins from the seeds
of Aesculus chinensis. Journal of Natural Products, 62, 1510–1513.
- Yoshikawa, M., Murakami, T., Matsuda, H., Yamahara, J., Murakami,
N., & Kitagawa, I. (1996). Bioactive saponins and glycosides. 3. Horse
chestnut. Chemical & Pharmaceutical Bulletin, 44, 1454–1464.
- Newell, E.A. (1991) Direct and delayed costs of reproduction
in Aesculus californica. Journal of Ecology 79, 365–378.
- Zhang Z, Li S (2007) Cytotoxic triterpenoid saponins from the
fruits of Aesculus pavia L. Phytochemistry 68:2075–2086
Data Analytics
Source Material Depth
This graph represents the unique prevalence of "Aesculus" within the Eflora local research library.
Penetration indicates the percentage of total documents containing at least one of the search terms.
Unique Sources: Books
125 / 943 vols
Unique Sources: Journals
34 / 1459 articles
Total Page Hits (Pages containing search term(s))
637
cumulative